Research Reports

Healthcare

icon
Home » Reports » Osteoarthritis Treatment Market Global Demand Growth Analysis Opportunity Outlook 2023
Market Research Report

Osteoarthritis Treatment Market : Global Demand, Growth Analysis & Opportunity Outlook 2023

Published On : 05:23 AM, 23rd April, 2018 REP-ID-195 Category: Healthcare

Global Osteoarthritis Treatment Market Overview

Osteoarthritis is a long-term chronic disease which occurs due to deterioration of cartilaginous muscles in joints and increases pain and stiffness in bone joint in the body. Usual symptoms of arthritis are redness and swelling on the affected part whereas obesity, overweight, infections and old age are the main causes for osteoarthritis.

The demand for osteoarthritis treatment market is estimated to expand in near future owing to rapid growth in aging population and increased personal disposable income in growing economies across the globe. Rapid growth in healthcare sectors supported by spiked investments in research and development aims to provide affordable and effective osteoarthritis treatments. These factors are estimated to swell the demand for osteoarthritis medications and other treatment in near future.

                     Osteoarthritis Treatment Market Demand, growth & Revenue Opportunity

Market size and forecast

The global osteoarthritis treatment market is projected to expand at a CAGR of 7.6% over the forecast period i.e. 2016-2023. The market of medications is expected to garner exponentially in terms of demand on account of cost-effectiveness and ease of availability.

Regionally, Asia-Pacific is expected to be the fastest growing and revenue generating market across the globe in near future. The market is driven by rapid increase in aging population in Asia-pacific regions such as Japan, China, etc. and increasing investment in healthcare sector in order to reduce the burden of diseases from aged population. Factors such as government initiatives and rise in personal disposable income in growing economies of Asia-Pacific region are expected to augment the demand for osteoarthritis treatment in near future.

Likewise, North America accounted the highest market share in terms of revenue in overall market of osteoarthritis treatment across the globe. The market of North America region is expected to continue its dominance over the forecast period i.e. 2016-2023 on the back of introduction of favorable re-imbursement policies in the region, rising obese population coupled with higher risk of osteoarthritis and rising awareness towards the treatment of osteoarthritis. Further, increase in healthcare expenditure across the globe in developing and under-developed nations are changing the scenario of healthcare sector in order to provide better and effective treatment. Emerging economies are adopting advanced therapies and healthcare treatments to minimize the burden of diseases which is further cutting down the figure of health expenditure. Rising awareness towards osteoarthritis in developing nations and introduction of favorable re-imbursement policies by the government organizations across the globe are likely to shift the consumer to adopt treatment for osteoarthritis in near future.

Market Segmentation

Our in-depth analysis segmented the global osteoarthritis treatment market in the following segments:

By Medications

  • Acetaminophen
  • Non-steroidal Anti-Inflammatory

By Therapies

  • Non-Pharmacological Therapy
  • Pharmacological Therapy
  • Surgical Treatment

By End-User

  • Hospitals
  • Clinics
  • Household

By Region

Global Osteoarthritis Treatment Market is further classified on the basis of region as follows:

  • North America (United States /U.S. & Canada)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Western and Eastern Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Western Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia)
  • Middle East and North Africa (MENA)
  • Rest of World

Growth Drivers and challenges

The market of osteoarthritis treatment is driven on the back of factors such as increase in aging population that is predicted to trigger the prevalence of chronic diseases such as osteoarthritis and leading to physical inactivity, stiffness and pain in joints, growing awareness towards osteoarthritis therapies for better treatment and early adoption of healthcare treatments to maintain fitness.

Furthermore, increase in personal disposable income, growing preference of consumers towards early treatments and preventions, availability of cost-effective & advanced osteoarthritis treatment drugs and rising awareness towards osteoarthritis and their treatment across the globe  are some of the key elements prompting the demand for osteoarthritis treatment over the forecast period i.e. 2016-2023.

However, high cost of treatment, lack of awareness in under-developed nations, poor treatment of osteoarthritis, and lack of skilled healthcare physicians are some of the factors likely to hamper the market growth of osteoarthritis treatment market across the globe.

Key Players

The key vendors of osteoarthritis treatment market are as follows:

  • Pfizer Inc
    • Company Overview
    • Key Product Offerings
    • Business Strategy
    • SWOT Analysis
    • Financials
  • Novartis AG
  • Johnson & Johnson Limited
  • Abbott Laboratories
  • Merck & Co
  • Eli Lilly and Company
  • Regeneron Pharmaceuticals
  • Abiogen Pharma Spa
  • Ampio Pharmaceuticals
  • Smith & Nephew, Inc

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The Global Osteoarthritis Treatment Market is segmented as follows:

  • By Medications type Market Size and Y-O-Y Growth Analysis
  • By Therapies type Market Size and Y-O-Y Growth Analysis
  • By End-user Market Size and Y-O-Y Growth Analysis

By Regions

  • North America (U.S., Canada) Market Size and Y-O-Y Growth Analysis
  • Latin America (Mexico, Brazil, Rest of Latin America) Market Size and Y-O-Y Growth Analysis
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe) Market Size and Y-O-Y Growth Analysis
  • Asia-Pacific (China, India, Singapore, Japan, Australia and New Zealand and Rest of Asia) Market Size and Y-O-Y Growth Analysis
  • Middle East and North Africa (MENA) Market Size and Y-O-Y Growth Analysis
  • Rest of World  Market Size and Y-O-Y Growth Analysis

Market Dynamics

Supply and Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

   key Answers            

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

1014, 10th Floor, Tower A1,
Ansal Corporate Park, Plot no 7A/1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

1820 Avenue M, Suite# 1113,
Brooklyn, New York 11230
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2018 Research Nester. All rights reserved

Top